CClinicalTrials.gg
Status unknownNCT04205760PROPER-LVADUpdated May 26, 2022

Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device

A Phase 3 interventional study of Nutrition + exercise in Left Ventricular Assist Device, End-stage Heart Failure and Cardiac Surgery, sponsored by RWTH Aachen University. Status unknown at 5 sites in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-05-26.

Sponsored by RWTH Aachen University · Phase 3, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 3
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a pilot, randomized, multicenter interventional trial of a combined preoperative oral nutritional support (ONS) and physical exercise therapy in patients planned for elective implantation of a left-ventricular assist device (LVAD). This pilot study pursues to demonstrate the feasibility and safety of a study protocol to optimize the patients' nutritional and physical state to reduce the number of postoperative complications and consequently to ameliorate the patients' outcome.

Read the detailed description

The oral nutrition supplementation will be started immediately after randomization and will be continued until surgery. The patients will receive a dosage of ONS adjusted to their nutritional risk. Regular monitoring of blood sugars, electrolytes, phosphate, and triglycerides will occur twice per week, as per standard protocol.

In-bed cycling will be started as soon as possible after randomization. Cycling sessions will be performed daily for 50 minutes, at least 5 times a week until surgery. Standard safety criteria will be assessed prior to initiating cycling treatments. The in-bed cycling will be performed passively or actively with graded increasing resistance. All cycling interventions will be performed under 1:1 supervision of medically trained study personnel while monitoring patient's heart rate, systolic and diastolic blood pressure and transcutaneous oxygen saturation of blood.

When evaluating the effect of a combined nutritional and exercise intervention, other important co-interventions should be standardized to reduce potential confounding of trial outcomes. All study patients should be fed with an oral diet that is in accordance to local standards, whereas it is strongly recommended to adhere to current clinical practice guidelines. Besides, the investigators highly encourage daily respiratory therapy in both groups plus mobilization as much as feasible.

All other key interventions during preoperative treatment will be standardized in accordance to the local clinical practice. Study teams will follow up on the patients on a daily base, documenting adherence with study interventions and key co-interventions.

Patients in the control group will not receive preoperative ONS. No bed cycling will be allowed from admission until surgery. Neither of these practices are the current standard of care in the participating unit.

02

Conditions studied

  • Left Ventricular Assist Device
  • End-stage Heart Failure
  • Cardiac Surgery

Browse trials for

Keywords

  • LVAD
  • preoperative optimization
  • end-stage heart failure
  • cardiac surgery
  • nutrition therapy
  • exercise
  • cycling
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 40 is below the median of 72 across 3,736 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

RWTH Aachen University is the lead sponsor of 228 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Given informed consent
  2. Adult patients (≥18 years)
  3. Patients undergoing elective LVAD implantation Additional cardiac surgery, such as bypass grafting, or valve repair is permitted

Exclusion criteria

Exclusion Criteria:

  1. Hospital admission \<5 days prior to planned LVAD implantation
  2. Patients on ECMO or INTERMACS\<1
  3. Patients already receiving nutrition support on hospital admission
  4. Enteral nutrition is contraindicated.
  5. Pregnant or lactating patients
  6. Patients with clinical fulminant hepatic failure
  7. Patients with cirrhosis Child's Class C Liver Disease
  8. Patients with clinical kidney failure or requiring hemodialysis
  9. Known allergy or intolerance to study nutrients
  10. Intracranial or spinal process affecting motor function
  11. Lower extremity impairments that prevent cycling
  12. Disabling neuropsychiatric disorders or language barriers
  13. Weight > 150 kg
  14. Enrolment in an industry sponsored randomized trial within the last 30 days (co-enrolment in academic randomized trials will be considered on a case by case basis)
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • No intervention
    Control group

    Standard Care as per local guidelines

  • Experimental
    Intervention

    Oral nutrition support (ONS) and bed-cycling before surgery

    Combination Product: Nutrition + exercise

Interventions

  • Combination productNutrition + exercise

    Patients will receive preoperative optimization consisting of oral nutrition support (Fresubin 3.2 kcal) and bed-cycling (50 minutes per day) for 5-14 days before surgery.

    Also known as: bed cycling, ONS

06

What researchers measure

Primary outcomes

  1. Comparison of adverse events

    adverse events between groups related to cycling and nutritional complications

    Time frame: up to 2 weeks before surgery

  2. Separation of caloric supplementation

    Separation between groups on prescribed caloric targets

    Time frame: up to 2 weeks before surgery

  3. Separation of protein supplementation

    Separation between groups on prescribed protein targets

    Time frame: up to 2 weeks before surgery

  4. Proportion of interventions received as prescribed

    Proportion of interventions received as prescribed

    Time frame: up to 2 weeks before surgery

  5. Rate of patients recruited per month

    Target: 1.5 patients per month

    Time frame: up to 18 months

  6. Ratio of control patients received physiotherapy

    Ratio of control patients received physiotherapy

    Time frame: up to 2 weeks before surgery

  7. Ratio of control patients received nutritional support

    Ratio of control patients received nutritional support

    Time frame: up to 2 weeks before surgery

Secondary outcomes

  1. mortality rates at day 30

    mortality rates at day 30

    Time frame: day 30 after randomization

  2. rates of ICU length of stay

    rates of ICU length of stay

    Time frame: up to 3 months

  3. rates of hospital length of stay

    rates of hospital length of stay

    Time frame: up to 3 months

  4. Mean duration of mechanical ventilation

    Mean duration of mechanical ventilation

    Time frame: up to 3 months

  5. Incidence of complications

    Incidence of complications

    Time frame: up to 3 months

  6. Incidence of infections

    Incidence of infections

    Time frame: up to 3 months

  7. Change in Mid-arm circumference

    baseline values versus follow-up values

    Time frame: up to 6 months

  8. Change in Muscle mass - Quadriceps thickness

    ultrasound, baseline values versus follow-up values

    Time frame: up to 6 months

  9. Change in Muscle mass - Quadriceps cross sectional area

    ultrasound, baseline values versus follow-up values

    Time frame: up to 6 months

  10. Change in Muscle strength - Handgrip strength

    Dynamometry, baseline values versus follow-up values

    Time frame: up to 6 months

  11. Change in Muscle strength - Quadriceps strength

    Dynamometry, baseline values versus follow-up values

    Time frame: up to 6 months

  12. Change of Clinical Frailty score (CFS)

    baseline values versus follow-up values; Score: 1-9 (very fit: 1, terminally ill: 9)

    Time frame: up to 6 months

  13. Change in Physical function - 6-Minute Walk Test

    baseline values versus follow-up values, 6-minute walking distance

    Time frame: up to 6 months

  14. Change in Physical function - Short Physical Performance Battery

    baseline values versus follow-up values,(Score: 0-12; 0=worst performance and 12=best performance)

    Time frame: up to 6 months

  15. Change in Physical function - Functional Status Score for the ICU

    baseline values versus follow-up values,(Score 0-35; the higher the score, the better physical functioning)

    Time frame: up to 6 months

  16. Change in quality of life - Lawton Instrumental Activities of Daily Living (IADL)

    baseline values versus follow-up values, (score 0-8; the higher the more independent)

    Time frame: up to 6 months

  17. Change in quality of life - Katz Activities of Daily Living (ADL)

    baseline values versus follow-up values,(Score: 0-100; the higher the more independent)

    Time frame: up to 6 months

  18. Quality of life - Short Form 36 (SF-36)

    baseline values versus follow-up values,(Score: 0-100; 100=no limitation in daily life and 0=completely limited)

    Time frame: up to 6 months

  19. Change in neurological function - Mini Mental State Examination

    baseline values versus follow-up values, (score: 0-30; the higher the less cognitively impaired)

    Time frame: up to 6 months

07

Study locations

2 of 5 sites recruiting
  • Heart Center Bad Oeynhausen
    Bad Oeynhausen, NRW, Germany
    • Vera von Dossow · Contact
    Recruiting
  • RWTH Aachen University
    Aachen, Germany
    • Aileen Hill, Dr. med. · Contact
    • Elena Laaf, MSc · Contact
    Recruiting
  • Heart Center Dresden
    Dresden, Germany
    • Klaus Matschke, Univ.-Prof. Dr. med. habil. · Contact
    Not yet recruiting
  • University Hospital Justus-Liebig University Giessen
    Giessen, Germany
    • Bernd Niemann, PD Dr. med. · Contact
    Not yet recruiting
  • University Medical Center Schleswig-Holstein, Campus Kiel
    Kiel, Germany
    • Bernd Panholzer, Dr. med. · Contact
    Not yet recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04205760
Lead sponsor
RWTH Aachen University
Responsible party
Christian Stoppe (Prof. Dr. med., RWTH Aachen University) — Principal investigator
First posted
Dec 19, 2019
Start date
Jan 2, 2022
Primary completion
Jul 2, 2023 (estimated)
Completion
Dec 2, 2023 (estimated)
Last update
May 26, 2022

Study contacts

Aileen Hill, Dr. med.
Contact
ahill@ukaachen.de
+49 241 80 ext. 38166
Elena Laaf, MSc
Contact
elaaf@ukaachen.de
+49 241 80 ext. 89021
Christian Stoppe, Prof. Dr. med.
principal investigator · RWTH Aachen University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion